TWiV 1076: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin highlights global circulation of Mpox virus, reviews the most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus in the US, and discusses the clinical outcome of hospitalized children under 5 years infected with SARS-CoV-2, the perinatal and neonatal outcomes including adverse effects of SARS-CoV-2 infection and virus transmission in Italy between early 2020 and 2022, the guidelines to improve home ventilation, the safety and efficacy of the oral anti-viral molnupiravir and the use of convalescent plasma as a long term treatment as well as treatment specifically for the immune compromised, the ineffectiveness of antibiotics for treating COVID-19, the association of olfactory dysfunction and the administration of corticosteroids and the safety of the RSV vaccines licensed last year.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Articles and graphs cited in TWIV CU 1076
- Global\xa0mpox\xa0circulation (WHO)
- Mpox in the\xa0Americas\xa0and Europe (CIDRAP)
- Respiratory\xa0\xa0disease\xa0surveillance (CDC)
- RSV\xa0surveillance\xa0 (CDC)
- RSV\xa0national\xa0trend (CDC)
- Influenza/flu\xa0surveillance\xa0\xa0(CDC)
- Influenza/flu\xa0map\xa0(CDC)
- COVID-19\xa0\xa0hospital\xa0admissions (CDC)
- COVID-19\xa0national\xa0trend (CDC)
- COVID-19\xa0wastewater\xa0testing (biobot)
- Vaccine-Eligible Children Under-5 Years\xa0(PIDJ)
- Pre-school cohort\xa0vaccination\xa0rate (CIDRAP)
- Perinatal\xa0transmission\xa0and neonatal outcomes (IJID)
- Adverse\xa0maternal and neonatal effect (dgalerts)
- Ventilation\xa0home\xa0improvements (CDC)
- Quarantine/isolation\xa0guidelines (CDC)
- Molnupiravir\xa0safety\xa0and efficacy (JMV)
- Convalescent plasma remmendation for\xa0immunocompromised\xa0(IDSociety)
- Corticosteroids\xa0in SARS-CoV-2
- Anticoagulation\xa0guidelines (hematology.org)
- Corticosteroids induced\xa0olfactory\xa0dysfunction (PLoS One)
- Convalescent Plasma Therapy:\xa0Long Term\xa0Implications (OFID)
- Preventing RSV\xa0infection\xa0by vaccination (MMWR)
- Antivirals and\xa0chronic kidney\xa0disease (CID) Early administraton of molnupiravir\xa0versus\xa0ritonavir-boosted nirmatrelvir (Lancet Infectious Diseases)
- Contribute to our\xa0MicrobeTV fundraiser at PWB
- Letters read\xa0on TWiV 1076
- Dr. Griffin\u2019s COVID treatment summary (pdf)
- Timestamps by\xa0Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv